Literature DB >> 11849450

Meprin, a brush-border enzyme, plays an important role in hypoxic/ischemic acute renal tubular injury in rats.

Simone Carmago1, Sudhir V Shah, Patrick D Walker.   

Abstract

BACKGROUND: It has been shown that non-congenic mice strains with lower levels of renal meprin develop less renal injury following renal ischemia and reperfusion. We have demonstrated that following ischemia-reperfusion renal injury, there is a rapid shift of meprin localization and intensity from the brush border to the cytoplasmic compartment, tubular lumens and the tubular basement membranes. Radical shifts in the localization of an activated enzyme to potentially sensitive areas of the tubule suggest a toxic role for meprin in ischemia-reperfusion injury. Though meprin degrades extracellular matrix components and other substrates, to our knowledge meprin cytotoxicity has never been examined. Therefore, the first objective of this study was to determine if meprin is directly cytotoxic to renal cells in vitro. The second objective was to determine if inhibition of meprin is protective against hypoxia-reoxygenation injury in vitro and ischemia-reperfusion injury in vivo.
METHODS: The immortalized porcine epithelial cell line (LLC-PK1) and Madin-Darby canine kidney (MDCK) cells in culture were exposed to meprin in various concentrations and for various times. Cell death was determined by Trypan Blue exclusion, lactate dehydrogenase (LDH) release and the 3-[4,5] dimethylthiazol-2,5-diphenyltetrazolium bromide (MTT) assay. Renal slices were used to examine the effect of the meprin inhibitor, actinonin, on hypoxic injury in vitro. Male Sprague-Dawley rats were used in ischemia-reperfusion injury studies to determine the effect of actinonin on renal function as measured by plasma urea nitrogen, creatinine and renal histology.
RESULTS: Meprin is cytotoxic to LLC-PK1 and MDCK cells in a concentration and time dependent manner. The meprin inhibitor 1,10-phenanthroline completely abolished the cytotoxic effect. Renal slices exposed to hypoxia and hypoxia followed by reoxygenation showed marked cell death. Pre-treatment with the actinonin was markedly protective while not interfering with the hypoxia-induced fall in adenosine 5'-triphosphate (ATP) levels. In in vivo studies, rats exposed to ischemia/reperfusion injury were markedly protected against acute renal failure by IP treatment with actinonin.
CONCLUSIONS: Meprin is cytotoxic to cultured renal tubular epithelial cells in vitro. Renal slices are protected from hypoxia-reoxygenation injury in vitro by the meprin inhibitor actinonin. Meprin inhibition is protective against rat renal hypoxia-reoxygenation injury. These data strongly support the concept that meprin is cytotoxic and may play a key role in renal ischemia-reperfusion induced renal injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849450     DOI: 10.1046/j.1523-1755.2002.00209.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  23 in total

Review 1.  Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury.

Authors:  Philip R Mayeux; Lee Ann MacMillan-Crow
Journal:  Pharmacol Ther       Date:  2012-01-16       Impact factor: 12.310

Review 2.  Meprin A metalloproteinase and its role in acute kidney injury.

Authors:  Gur P Kaushal; Randy S Haun; Christian Herzog; Sudhir V Shah
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-20

Review 3.  Role of meprin metalloproteinases in cytokine processing and inflammation.

Authors:  Christian Herzog; Randy S Haun; Gur P Kaushal
Journal:  Cytokine       Date:  2018-12-20       Impact factor: 3.861

4.  Actinonin, a meprin A inhibitor, protects the renal microcirculation during sepsis.

Authors:  Zhen Wang; Christian Herzog; Gur P Kaushal; Neriman Gokden; Philip R Mayeux
Journal:  Shock       Date:  2011-02       Impact factor: 3.454

5.  Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors.

Authors:  Markus-N Kruse; Christoph Becker; Daniel Lottaz; Danny Köhler; Irene Yiallouros; Hans-Willi Krell; Erwin E Sterchi; Walter Stöcker
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

Review 6.  Meprins, membrane-bound and secreted astacin metalloproteinases.

Authors:  Erwin E Sterchi; Walter Stöcker; Judith S Bond
Journal:  Mol Aspects Med       Date:  2008-08-22

7.  B-type natriuretic peptide 8-32, which is produced from mature BNP 1-32 by the metalloprotease meprin A, has reduced bioactivity.

Authors:  Guido Boerrigter; Lisa C Costello-Boerrigter; Gail J Harty; Brenda K Huntley; Alessandro Cataliotti; Harald Lapp; John C Burnett
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-04-22       Impact factor: 3.619

8.  Critical amino acids in the active site of meprin metalloproteinases for substrate and peptide bond specificity.

Authors:  James P Villa; Greg P Bertenshaw; Judith S Bond
Journal:  J Biol Chem       Date:  2003-07-29       Impact factor: 5.157

9.  Targeted disruption of the meprin beta gene in mice leads to underrepresentation of knockout mice and changes in renal gene expression profiles.

Authors:  Lourdes P Norman; Weiping Jiang; Xiaoli Han; Thomas L Saunders; Judith S Bond
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

10.  Meprin A and meprin alpha generate biologically functional IL-1beta from pro-IL-1beta.

Authors:  Christian Herzog; Randy S Haun; Varsha Kaushal; Philip R Mayeux; Sudhir V Shah; Gur P Kaushal
Journal:  Biochem Biophys Res Commun       Date:  2009-01-07       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.